Benzinga | Jan 28, 2021 07:03AM EST

Truist Securities Initiates Coverage On Exact Sciences with Buy Rating, Announces Price Target of $226

Truist Securities analyst Sandy Draper initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Buy rating and announces Price Target of $226.